INBX

INBX R&D Expense Growth

-44.52%Fiscal year

Period ending:

INBX FY R&D Growth (YoY)%
INBX FY R&D Growth (YoY)87.13%-58.63%
2016-12-312025-12-31

Source: Financial Modeling Prep (FMP). Annual fiscal periods. Dates are period ends; a fiscal year may differ from a calendar year. Growth compares with the corresponding period one year earlier.

INBX r&d expense growth history

Year-over-year research & development expense growth. The available annual fiscal periods series contains 10 observations from Dec 31, 2016 to Dec 31, 2025.

Inhibrx Biosciences Inc R&D Expense Growth — Annual fiscal periods
Period endingR&D Expense Growth
-44.5242%
6.8687%
73.0238%
54.2357%
-2.7961%
53.4118%
43.2026%
31.1407%
50.1295%
0%

Compare r&d expense growth

All INBX financial metrics · INBX stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.